APLN and Parkinson disease: As mentioned above, apelin signaling is affected by aging (Sauvant et al., 2014), is connected with several neurological disorders (Cheng et al., 2012), and is neuroprotective in mouse models of PD (Haghparast et al., 2018; Zhu et al., 2020).